| Financial Year |
March 31 2023 |
| Monetary Funds |
107,408,146.32 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
180,936,674.88 |
| Accounts Receivable |
229,258,028.32 |
| Advances to Suppliers |
8,263,805.89 |
| Other Receivables |
5,803,336.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
183,971,174.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,395,070.68 |
| Total Current Assets |
794,601,793.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
577,234,742.42 |
| Under-construction Projects |
85,261,265.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
36,809,091.89 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,994,166.39 |
| Deferred Income Tax Assets |
23,616,540.48 |
| Other Non-Current Assets |
8,169,058.57 |
| Sub-Total of Non-Current Assets |
734,773,635.83 |
| Total Assets |
1,529,375,429.21 |
| Short-Term Loans |
270,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
35,129,000.00 |
| Accounts Payable |
151,981,921.98 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,654,864.70 |
| Taxes Payable |
4,789,790.73 |
| Interest Payable |
388,933.33 |
| Dividend Payable |
-- |
| Other payables |
523,173.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
26,410,881.08 |
| Other Current Liabilities |
129,229,254.42 |
| Sub-Total of Current Liabilities |
626,100,513.63 |
| Long-term Loans |
85,800,732.84 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,544,036.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
90,651,019.38 |
| Total Liabilities |
716,751,533.01 |
| Paid-In Capital(Or Share Stock) |
124,972,581.00 |
| Capital Surplus |
486,947,934.87 |
| Surplus Reserve |
31,795,494.63 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
170,997,079.24 |
| Minority Stockholder's Interest |
-2,089,193.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
814,713,089.74 |
| Owner's Equity（Stockholder's Equity） |
812,623,896.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,529,375,429.21 |
